Jingxiao Chen

机构：Fujian University of Traditional Chinese Medicine, Shanghai Jiao Tong University, Regeneron (United States), Lishui University, Lishui Central Hospital, Progenics Pharmaceuticals (United States), Lishui City People's Hospital, The University of Texas Health Science Center at Houston · ORCID：0000-0003-2461-4616

发表论文 79 篇 · 总被引 1149 次 · h-index 18

代表论文

• Resveratrol prevents Ang II-induced cardiac hypertrophy by inhibition of NF-κB signaling (2023 · Biomedicine & Pharmacotherapy · 被引 37)
• Prompting Depth Anything for 4K Resolution Accurate Metric Depth Estimation (2025 · 被引 21)
• Manipulation of low-refractive-index particles using customized dark traps (2024 · Photonics Research · 被引 16)
• Inhibition of a novel Dickkopf-1-LDL receptor–related proteins 5 and 6 axis prevents diabetic cardiomyopathy in mice (2023 · European Heart Journal · 被引 14)
• Integrating, Harmonizing, and Curating Studies With High-Frequency and Hourly Physiological Data: Proof of Concept from Seven Traumatic Brain Injury Data Sets (2023 · Journal of Neurotrauma · 被引 8)
• Prevalence, clinical characteristics and outcomes of seizures in neurofibromatosis type 1: A systematic review and single arm meta-analysis (2024 · Epilepsy Research · 被引 6)